Library — CHDR

Search

Filter

Key publication (484)
Poster (20)
PhD Thesis (16)
Brochure (19)
Factsheet (4)
Annual report (6)

Implications of the BIA-102474-101 study for review of first-into-human clinical trials.

Eddleston M, Cohen AF, Webb DJ

British journal of clinical pharmacology, 2016 Mar; 81(4):582-6

View publication
Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.

Guan Z, Klumpers LE, Oyetayo OO, Heuberger J, van Gerven JM, Stevens J

British journal of clinical pharmacology, 2016 Mar; 81(4):713-23

View publication
A PK-PD model-based assessment of sugammadex effects on coagulation parameters.

Bosch R, van Lierop MJ, de Kam PJ, Kruithof AC, Burggraaf J, de Greef R, Visser SA, Johnson-Levonas AO, Kleijn HJ

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016 Mar

View publication
Sputum RNA signature in allergic asthmatics following allergen bronchoprovocation test.

Zuiker RG, Tribouley C, Diamant Z, Boot JD, Cohen AF, Van Dyck K, De Lepeleire I, Rivas VM, Malkov VA, Burggraaf J, Ruddy MK

European clinical respiratory journal, 2016 Mar

View publication
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.

van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J

The European respiratory journal, 2016 Feb; 47(3):889-97

View publication
NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects.

Zuiker RG, Chen X, Østerberg O, Mirza NR, Muglia P, de Kam M, Klaassen ES, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2016 Feb; 30(3):253-62

View publication
Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.

Kervezee L, Stevens J, Birkhoff W, Kamerling IM, de Boer T, Dröge M, Meijer JH, Burggraaf J

British journal of clinical pharmacology, 2016 Jan; 81(2):256-68

View publication
Digoxin and mortality: lessons for observational studies.

de Boer A, Cohen AF

British journal of clinical pharmacology, 2015 Dec; 81(1):4-5

View publication
Olaparib.

Goulooze SC, Cohen AF, Rissmann R

British journal of clinical pharmacology, 2015 Dec; 81(1):171-3

View publication

«
1
2
3
4
5
6
7
8
...
53
54
»